Of these NLRs, NLRP12 is the prototypical member and has been shown to negatively regulate components of both canonical and non-canonical NF-κB pathways in vitro and more recently found to display this role in vivo in colitis and colon cancer models [14], [16]. This evidence concerns the gene NLRP12 and malignant colon neoplasm.